Pedro Beltran

Pedro Beltran is a declared insider of BridgeBio Oncology Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 10 March 2026 to 1 October 2026, the count stands at 3 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 5 October 2026, the filings show a share grant worth €3,639 in BridgeBio Oncology Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.